radiopharmtheranostics.com (RADX): Net earnings per share growth forecast for next year

Symbol and logo of brand Radiopharm Theranostics (RADX)

Radiopharm Theranostics (RADX) maintains a business model resilient to macroeconomic crises, as demand for oncology innovations remains constant. Operations are strictly regulated by radioactive waste disposal standards. The earnings per share (EPS) forecast for the coming year clearly demonstrates expert expectations, where the 0.00 indicator determines the parameter status. This reinforces the company's pricing power due to its ownership of rare isotopes used for the targeted destruction of cancer cells.

RADX: radiopharmtheranostics.com Earnings growth forecast for next year 12/06/2024 - 11/15/2026

RADX (Radiopharm Theranostics Ltd): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Fundamental company analysis:RADX, Radiopharm Theranostics Limited
Finished products of Radiopharm Theranostics Limited

When screening for issuer reliability, this indicator serves as a filter for market optimism regarding future profitability. It is calculated as the percentage ratio of the expected earnings per share (EPS) for the following year to the current value, reflecting the analysts' consensus forecast. For Radiopharm Theranostics (RADX), the forward growth vector of EPS for the coming year confirms the capitalization of the intellectual potential of nuclear medicine specialists and the stability of the research staff.

Who Radiopharm Theranostics competes with

ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Therapeutics HALO|Net earnings per share growth forecast for next year Revolution Medicines, Inc. (RVMD)|Earnings growth forecast for next year Ascentage Pharma Group International (AAPG)|Earnings growth forecast for next year CGON (CG Oncology Inc)|Expected earnings per share trend next year URGN|bicara.com - Earnings growth forecast for next year|Expected earnings per share trend next year PSNL (personalis.com)|Erasca Inc (ERAS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Delcath Systems|YMAB (YmAbs) - Earnings growth forecast for next year|AURA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Candel Therapeutics, Inc. (CADL)|Earnings growth forecast for next year Accuray (ARAY)|Net earnings per share growth forecast for next year SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Expected net earnings per share growth next year|CTOR - Net earnings per share growth forecast for next year|HURA: Net earnings per share growth forecast for next year|TARA (Protara) - Expected earnings per share growth for next year|Fate Therapeutics, Inc. - Expected earnings per share trend next year|WHWK (aadibio.com) - Earnings growth forecast for next year|TCRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Champions Oncology (CSBR)|XBiotech - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year CEL-SCI CVM|Consensus forecast of earnings per share growth for next year OS Therapies (OSTX)|Artiva - Earnings growth forecast for next year|ANL: Net earnings per share growth forecast for next year|VERU: Earnings growth forecast for next year|Net earnings per share change forecast for next year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year renovarobio.com RENB|Net earnings per share growth forecast for next year muraloncology.com (MURA)|Projected earnings per share increase next year KAPA|Earnings growth forecast for next year OKUR (onkuretherapeutics.com)|Projected earnings per share increase next year GDTC (CytoMed)|Curis - Earnings growth forecast for next year|APLM: Net earnings per share growth forecast for next year|Tharimmune (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth forecast for next year|Calidi Biotherapeutics (CLDI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year SBFM|Net earnings per share growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|Earnings growth forecast for next year SLRX (salariuspharma.com)|PPBT - Expected earnings per share growth for next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeOne Medicines)|CKPT: Earnings growth forecast for next year|Elevation Oncology Inc. (ELEV) - Earnings growth forecast for next year|ICAD (iCAD) - Earnings growth forecast for next year|Earnings growth forecast for next year ikenaoncology.com|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year